Follow Flash Finance FollowTelegram
61tech score
/ 100

Shukra Pharmaceuticals Limited (SHUKRAPHAR) — Technical Setup

₹82.20 +0.02%   Strong Uptrend Normal Volatility Bullish

As of 2026-11-12 close Sector: Pharma Pharmaceuticals All technical setups →

Summary

Shukra Pharmaceuticals Limited is in a strong uptrend on the daily chart. RSI(14) is 78.4, MACD is above its signal line, ADX reads 42 (trending). Volume in the latest session was 0.3× its 20-day average. Nearest support is ₹75.40, with no swing resistance overhead. Its technical score is 61/100 (bullish).

Trend (daily)
Bullish
Trend (weekly)
—
Trend (monthly)
—
RSI (14)
78.36
MACD
Bullish
ADX (14)
41.67
Volume vs 20d avg
0.25×
Support
₹75.40 (−8.3%)
Resistance
None overhead
RS vs Nifty (3M)
—
RS rating
—

🧮 How the 61/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend12/20
  • Close above 20-day EMA (9.77)3/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA0/3
  • SuperTrend (10,3) pointing up3/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (41.67)3/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum16/20
  • RSI(14) in the bullish zone (55-70 best) (78.35)4/6
  • MACD line above its signal line4/4
  • MACD line above zero (5.37)3/3
  • 12-day rate of change positive (21.85)3/3
  • Stochastic %K above %D2/2
  • Outperforming the Nifty 50 over 3 months0/2
Volume15/20
  • On-balance volume rising over 20 sessions5/5
  • Chaikin Money Flow (20) positive (-0.20)0/5
  • More volume on up days than down days (20 sessions) (3.18)5/5
  • Close above 20-day VWAP (12.37)5/5
Volatility12/20
  • Daily range (ATR%) contained — ≤2.5% scores full (5.19)2/6
  • Price in the upper half of its Bollinger Bands (0.83)5/5
  • Shallow drawdown from the 52-week high (-2.72)5/5
  • Volatility contracting (20-day volatility below its 6-month median)0/4
Support / Resistance6/20
  • Room to the next resistance (≥8% scores full)0/5
  • Support close below (a tight, definable stop) (8.27)1/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-2.72)5/5

🧭 Regime: Strong Uptrend

Normal Volatility — Bollinger width is in the 58th percentile of the last six months.

Suits: Trend-following. Pullbacks to the 20-day EMA and breakouts tend to be bought in strong trends; mean-reversion shorts fight the tape.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the Momentum Breakout rules for SHUKRAPHAR — close at a 20-day high on 1.5× average volume, rsi above 55.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly———
Weekly———
Daily▲ Bullish78.360.42

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.

📶 Volume & VWAP

Relative volume
0.25×
5d / 20d volume
0.47×
Volume ROC (10d)
+18.76%
Up/down volume
3.18×
OBV (20d)
Rising
Chaikin MF (20)
-0.20
VWAP 20d
₹73.15 (+12.37%)
VWAP 50d
₹67.58 (+21.63%)
Anchored VWAP · 52W low
₹66.79 (+23.07%)
Anchored VWAP · 52W high
₹82.61 (-0.50%)
Anchored VWAP · YTD
₹66.79 (+23.07%)
Avg turnover (20d)
₹58 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal.

💪 Relative strength

vs Nifty 1M
+10.54%
vs Nifty 3M
—
vs Nifty 6M
—
vs Nifty 1Y
—
RS rating
—
Mansfield RS
—
vs Pharma index 3M
—
vs sector peers 3M
—

SHUKRAPHAR ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Close₹82.20—
Support₹75.40−8.3%1
Support₹71.73−12.7%1
Support₹58.20−29.2%1
Support₹50.03−39.1%1

52-week range: ₹40.06 – ₹84.50 (-2.72% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹40.06 (2026-08-14) to ₹84.50 (2026-11-09). Price has retraced 5.2% of it.

RatioPriceDistance
23.6% retracement₹74.01-10.0% nearest
38.2% retracement₹67.52-17.9%
50.0% retracement₹62.28-24.2%
61.8% retracement₹57.04-30.6%
78.6% retracement₹49.57-39.7%S/R confluence
127.2% extension₹96.59+17.5%
161.8% extension₹111.96+36.2%
200.0% extension₹128.94+56.9%

Next Fibonacci time zone: 89 sessions from the swing start ≈ 2026-12-23 (approximate — exchange holidays are not modelled).

🕯️ Candlesticks (last 5 sessions)

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
GLANDGland Pharma Limited ₹3,308.70 +1.37% 91 Strong Uptrend 93.00
AARTIPHARMAarti Pharmalabs Limited ₹1,010.50 +9.42% 90 Strong Uptrend 84.00
DRREDDYDr. Reddy's Laboratories Limited ₹1,386.60 +0.70% 88 Strong Uptrend 76.00
ANTHEMAnthem Biosciences Limited ₹938.45 -1.99% 87 Strong Uptrend 83.00
AUROPHARMAAurobindo Pharma Limited ₹1,807.20 -1.11% 87 Strong Uptrend 87.00
BAFNAPHBafna Pharmaceuticals Limited ₹491.85 +1.99% 87 Strong Uptrend 99.00
GLENMARKGlenmark Pharmaceuticals Limited ₹2,659.80 -0.65% 87 Strong Uptrend 85.00
APLLTDAlembic Pharmaceuticals Limited ₹1,047.25 +1.68% 86 Strong Uptrend 85.00
LAURUSLABSLaurus Labs Limited ₹2,400.00 -1.19% 84 Strong Uptrend 97.00
AARTIDRUGSAarti Drugs Limited ₹508.75 +3.84% 83 Strong Uptrend 82.00
🔗 More on SHUKRAPHAR

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI